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Immunoreactivities of peptides purified after cleavage ofhuman liver apoferritin are reported and discussed 
in relation to the known 3-dimensional and primary structures of homologous apoferritins. These studies 
point to 3 antigenic sites occupying continuous inter-helical regions of the polypeptide chains which lie on 
the surface of the apoferritin molecule. Other antigenic regions may encompass amino acids remote in the 
primary structure or belonging to different subunits. 
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1. INTRODUCTION 
The iron-storage protein, ferritin, is a widely 
distributed protein composed of 24 subunits [l]. 
Tissue ferritin levels are responsive to iron and this 
is generally reflected in its concentration in serum. 
Elevated tissue and serum ferritin levels may also 
occur in some disease states including some forms 
of malignancy. Immunoassay is widely used to 
monitor these levels [2]. However, such assays are 
complicated by the presence in ferritin of two 
subunits, known as H and L; the H subunit being 
more prevalent in heart and the L in liver and 
spleen [3]. Heart and liver or spleen ferritins differ 
immunologically and, indeed, ferritins from a 
single tissue can be fractionated into species vary- 
ing in their immunoreactivities in parallel with 
their subunit content [4]. Cancer ferritins are 
usually H-rich but some investigators have sug- 
gested they may be abnormal, possibly represent- 
ing carcino-foetal types [5]. 
The 3-dimensional structures of apoferritins 
from liver and spleen of horse, human and rat are 
homologous [12]. That of horse spleen has been 
refined at 2.8 A resolution [l]. Examination of this 
structure, which is a symmetrical arrangement of 
24 subunits of high helix content, suggests ome of 
the antigenic determinants may be located in inter- 
helical regions on the molecular surface. 
Our studies aim to locate and characterise an- 
tigenic sites on the surface of the known structure 
of the ferritin molecule in order to understand the 
immunological differences between various tissue 
ferritins and also between the two subunits (H and 
L). We compare immunoreactivities of peptides 
produced by enzymic or chemical cleavage during 
the primary sequence determination of human 
liver apoferritin [7], to a variety of antisera. They 
will be discussed in relation to the known 
3-dimensional structure of the intact ferritin 
molecule and to sequence differences between 
human H and L subunits. 
Sequences corresponding to two distinct amino 
acid subunits in human spleen [6] and liver [7,8] 
and in rat liver ferritin [9] have recently been deter- 
mined either as amino acid or as cDNA sequences. 
Homologies between the L subunit sequences of 
horse [lo], human and rat (-85%) are greater than 
those between the two human liver sequences 
(presumed H and L, 57%) [7,11]. 
2. MATERIALS AND METHODS 
Ferritin was prepared from human liver and 
spleen, horse spleen and rat liver and purified 
essentially as described in [13]. Antisera to human 
and horse spleen and to rat liver ferritin were ob- 
tained as in [14]. Two monoclonal antibodies to 
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human liver ferritin were a gift from Dr J. 
Gauldie. Human liver ferritin was reduced to 
apoferritin and peptides were isolated from it as 
described in [7]. Chemicals for immunological 
detection of peptides were purchased from Sigma 
(Poole, Dorset). Nitrocellulose membranes and the 
colour development reagent for the peroxidase 
reaction were obtained from Bio-Rad (Caxton 
Way, Watford). The dot immunobinding assay 
was carried out initially according to [15] or in 
later assays following the method of [16] with 
alkaline phosphatase conjugated second anti- 
bodies. 
lesser extent. A few peptides (46-53, 53-59 and 
97-100) show little or no reactivity. The complete 
amino acid sequence of human liver apoferritin 
(presumed L subunit) is shown in fig.2 and is com- 
pared with sequences of horse spleen and rat liver 
L subunit and human liver H subunit. Fig.3 gives 
relative antigenicities of human liver peptides to 
homologous polyclonal antiserum. 
Fig.4 shows a ribbon diagram of an apoferritin 
subunit and a diagrammatic representation of the 
CORPARISON OF =ITIN SEQUSNCES 
3. RESULTS AND DISCUSSION 
Fig.1 shows typical results indicating the reac- 
tivities as, shown by the dot immunobinding assay, 
of human liver peptides towards unfractionated 
antisera raised to human spleen, horse spleen, or 
rat liver ferritins and to two anti-human liver fer- 
ritin monoclonal antibodies. Immunoreactivities 
of the unfractionated ferritins are also shown. It is 
striking that there is extensive interspecies cross- 
reactivity and that this applies both to the reac- 
tivities of the human liver peptides towards the 
polyclonal antibodies and to the three ferritin 
preparations towards the human liver monoclo- 
nals. One peptide (sequence 145-174) shows mark- 
ed reactivity towards both monoclonals and 
polyclonals. Three other peptides, 83-91, 121-140 
and 76-82 towards polyclonal antisera give some 
reaction and several other peptides react but to a 
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Fig. 1. Dot immunobinding assay of peptides, from 
human liver apoferritin, horse spleen, rat liver and 
human liver apoferritins and bovine serum albumin 
(BSA), with antisera to horse spleen ferritin, rat liver 
ferritin, human spleen ferritin and two monoclonal 
antibodies to human liver ferritins. Peptides are 
2) RANFP 
Fig.%. Comparison of ferritin sequences. Sequences 
displayed are: 1, Human liver apoferritin (L subunit) [7]; 
2, human liver apoferritin (H subunit) 18); 3, human 
spleen apoferritin [6]; 4, horse spleen apoferritin [lo]; 5, 
rat liver apoferritin [9]; 6, &residue insertion in rat liver 
numbered as in the amino acid sequence. apoferritin [9]. 
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Fig.3. Schematic representation of positions of helices 
and antigenic reactivities of peptides from human liver 
apoferritin against antiserum to human spleen ferritin. 
Antigenic reactivities, as seen in the dot immunobinding 
assay, are graded on a scale of O-5. 
Fig.4 Ribbon diagram of one of the apoferritin subunits 
and diagrammatic representation of the 24-subunit 
quaternary structure, both viewed from the outside of 
the protein shell. Immunoreactive regions are indicated 
by the arrows. Every 10th residue is indicated on the 
ribbon diagram by a dot. 
24-subunit quaternary structure both viewed from 
the outside of the apoferritin shell. From these it 
can be seen that peptides found to be markedly im- 
munoreactive contain regions (indicated by ar- 
rows) which are both non-helical and situated on 
the outside of the molecule. Thus peptide 145-174 
encompasses the DE turn between helices D and E 
(although it includes regions within D and E which 
are buried); peptide 83-91 runs from the C- 
terminal end of a short region of &ribbon in the 
BC loop to the beginning of helix C entirely on the 
outside of the molecule (although some of its side 
chains are directed away from the surface); 76-82 
is also on the external BC loop in the section mak- 
ing a short region of anti-parallel pleated sheet and 
121-140 begins at the CD turn, although it pro- 
ceeds into a region of the D helix which is buried. 
These regions, particularly 83-91 and 151-159 are 
those that might be expected to contain antigenic 
determinants on the basis of the known structure 
and the finding in other proteins of such deter- 
minants within surface non-helical oops [17]. It is 
of interest o note that the three non-helical regions 
are situated near symmetry axes in the quaternary 
structure. Of peptides showing little or no reactivi- 
ty, 46-53 and 53-59, both from the B helix, are 
completely buried and 97-100 is very short. The 
peptides showing modest reactivity include 
144-153 and 154-174 and the lowered activity of 
these peptides as compared with 145-174 may 
mean that the integrity of the region 15 1-159 must 
be preserved for full activity. Of the other weakly 
reacting peptides, 98-104 is within the C helix with 
4 of its side chains (Ala, Val, Leu and Lys) facing 
outwards from the surface and 92-97, also within 
C, has 3 outward facing side chains (Leu, Asp and 
Lys) and again 112-120, also in the C-helix, has 6 
external side chains (Asp, Ala, Leu, Ser, Ala and 
Gln). Peptides 68-72 and 169-172 (both showing 
very weak reactivity) are buried, however. The fact 
that they are found to react at all, may be due to 
disruption of the structure either as a result of mix- 
ing with adjuvant or after injection into the rabbit, 
so that antibodies are raised to these normally 
buried regions. 
Cross-reactivities of the peptides and whole 
molecules with heterologous antisera deserve com- 
ment. Peptides 83-91 from L sequences are very 
similar with 85 Ala or Ser, 86 either Gln or Glu and 
91 either Lys or Thr, the other residues (including 
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Asp 87 and Glu 88) are identical. 121-140 and 
76-82 are also largely homologous. However, the 
marked cross-reactivity of 145-174 is interesting 
and perhaps surprising in view of the findings that 
the L-subunit of rat liver ferritin contains an inser- 
tion of 8 residues following residue 158 and there 
are apparently several other substitutions in this 
region. The reactivity of the two human 
monocionals is somewhat less towards the rat fer- 
ritin than towards the human. Although we have 
no data on immunoreactivities of human L- 
peptides to H-specific monoclonals, sequence com- 
parisons may be instructive. A considerable 
number of the amino acid substitutions, although 
by no means all, fall on the outside of the molecule 
and some of these may be antigenic determinants. 
It is particularly noteworthy that several substitu- 
tions are obvious in peptide 83-91, this region 
showing much less homology in human H and L 
subunits than is found in the L subunits of the 
three species compared. This strengthens the 
assignment of this region as one containing an- 
tigenic determinants, and one which may be 
responsible for some of the differences in reac- 
tivities of L- and H-rich ferritin molecules. Other 
such regions could include, for example, 92-97 
where there are 4 changes including Pro, Leu and 
Lys, Glu. It should also be borne in mind that here 
we have only examined continuous regions of se- 
quence and that many of the antigenic regions may 
be ‘conformational’ and comprise amino acids 
remote in sequence or belonging to neighbouring 
subunits. Indeed, this is suggested by further 
studies with fractionated antisera which have pro- 
vided populations reacting with whole molecules 
but with much diminished activity towards the 
peptides. However, the structure is a rather com- 
pact arrangement and if flexibility is important in 
antibody recognition then the continuous se- 
quences we have pin-pointed seem to belong to 
regions most able to meet this criterion. We hope 
that this and subsequent studies will provide the 
basis for an understanding of the specificity of fer- 
ritin antibody recognition. 
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